Mon, Jan 26, 2015, 4:53 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

DexCom, Inc. (DXCM) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • dxcm_sugar_daddy dxcm_sugar_daddy Apr 22, 2006 8:30 PM Flag

    Listen to Dexcom Webcasts!

    I'm not saying there isn't a need in this market. I am saying that DXCM is highly overvalued and that I don't think DXCM can ramp revenues fast enough, given the issues we've discussed, to justify a market cap of $640 million (current price + additional shares being sold in the current offering.) Device companies sell for 5x revenues or so, so the current valuation imputes revenues, on a discounted basis, of well north of $150-200 million per year--with no reimbursement, big, entrenched competitors, etc. Risk of not delivering is enormous.

    The survey is interesting, but the participants are self-selected, not randomly-selected, which creates huge bias issues. We got the 500 people who represent the target market for initial continuous glucose monitoring products: tech savvy, web-surfing, Type-1 pumpers. A market size of 500-1000 is probably about right for the first few years.

    Have you bought a continuous glucose monitor yet? If so, which brand and why?

62.78+4.84(+8.35%)4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.